Bharat biotech’s covaxin got its approval for jabbing children under 18
An expert panel on Tuesday recommended Covaxin – Bharat Biotech’s COVID-19 vaccine – for use on children between the ages of two and 18.
“Bharat Biotech has submitted data from clinical trials in the two – 18 age group for Covaxin to CDSCO (Central Drugs Standard Control Organisation). The data has been thoroughly reviewed by the Subject Expert Committee (SEC)… provided positive recommendations,” the Hyderabad-based company said.
we will get a vaccine for children between two and 18… it will be approved soon. SEC has recommended… trials were conducted keeping in mind the safety of children. We are committed to their safety,” said junior Health Minister Dr. Bharti Pravin Pawar
Data on these trials have not been made public yet, but tests were conducted on 1,000+ children across the country. The panel, however, noted the trial on kids showed similar efficacy rates as that on adults.
The reason for blackout in china is different from India Read on yourcoimbatore.com